Synchrony Labs

Executive Summary

Synchrony Labs is a preclinical medical device testing and regulatory consulting company headquartered in San Francisco. Founded in 2020, the firm specializes in GLP-compliant research services, with a particular focus on cardiovascular models and FDA approval support for medical device and pharmaceutical clients. Leveraging deep academic cardiology roots, Synchrony Labs aims to deliver high-integrity data that accelerates the transition of innovations from preclinical to clinical stages. Operating in the digital health and AI/ML categories, the company is positioned to address the growing demand for reliable preclinical testing in a regulatory environment that increasingly values robust evidence. While still in the preclinical stage and privately held, Synchrony Labs has the potential to become a key partner for medtech and pharma companies seeking to streamline their development pathways. Its early stage suggests significant upside if it can establish a track record of successful client engagements and expand its service offerings.

Upcoming Catalysts (preview)

• Q3 2026First major client partnership or contract announcement70% success
• TBDExpansion of service lines to include additional therapeutic areas50% success
• Q4 2026Series A funding or strategic investment60% success